Cormorant Asset Management VC
Investments by market, targeted sectors and preferred funding rounds
Investments by industry
biotech - 56%
healthtech - 44%
Number of investments: 9
Cormorant Asset Management invested in Monte Rosa Therapeutics during a round worth $95,000,000 - 3/16/2021
Cormorant Asset Management invested in Neurelis during a round worth $114,000,000 - 3/11/2021
Cormorant Asset Management invested in Ventyx Biosciences during a round worth $114,000,000 - 3/9/2021
Cormorant Asset Management invested in DTx Pharma during a round worth $100,000,000 - 3/5/2021
Cormorant Asset Management invested in Verve Therapeutics during a round worth $94,000,000 - 1/19/2021
Cormorant Asset Management invested in Affinivax during a round worth $226,000,000 - 1/8/2021
Cormorant Asset Management invested in Elevation Oncology during a round worth $65,000,000 - 11/19/2020
Cormorant Asset Management invested in Pharvaris during a round worth $80,000,000 - 11/18/2020
Cormorant Asset Management invested in Ambrx during a round worth $200,000,000 - 11/9/2020